<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<?covid-19-tdm?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2024.1365744</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Pattern and associated factors of COVID-19 knowledge, attitude and practice (KAP) among COVID-19-comorbid patients: a systematic review and meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rehman</surname> <given-names>Anees ur</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/899170/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Tasleem</surname> <given-names>Zermina</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Muhammad</surname> <given-names>Sohail Ayaz</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Rasool</surname> <given-names>Muhammad Fawad</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/836634/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Shah</surname> <given-names>Shahid</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Jabeen</surname> <given-names>Gul</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Arif</surname> <given-names>Sonia</given-names></name>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Omar Babkair</surname> <given-names>Lujain Salim</given-names></name>
<xref ref-type="aff" rid="aff7"><sup>7</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kadumi</surname> <given-names>Yahya Jaber</given-names></name>
<xref ref-type="aff" rid="aff8"><sup>8</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2653767/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Alghamdi</surname> <given-names>Saleh</given-names></name>
<xref ref-type="aff" rid="aff9"><sup>9</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1292830/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Almarzoky Abuhussain</surname> <given-names>Safa S.</given-names></name>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1983564/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Khayyat</surname> <given-names>Sarah M.</given-names></name>
<xref ref-type="aff" rid="aff10"><sup>10</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Alharthi</surname> <given-names>Raed Hamed Hilal</given-names></name>
<xref ref-type="aff" rid="aff11"><sup>11</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2628203/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Hossain</surname> <given-names>Mohammad Akbar</given-names></name>
<xref ref-type="aff" rid="aff12"><sup>12</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Abbas</surname> <given-names>Asma A.</given-names></name>
<xref ref-type="aff" rid="aff13"><sup>13</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2621605/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Elrggal</surname> <given-names>Mahmoud Essam</given-names></name>
<xref ref-type="aff" rid="aff13"><sup>12</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/891006/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Haseeb</surname> <given-names>Abdul</given-names></name>
<xref ref-type="aff" rid="aff14"><sup>14</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/613892/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University</institution>, <addr-line>Multan</addr-line>, <country>Pakistan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Political Sciences, Bahauddin Zakariya University</institution>, <addr-line>Multan</addr-line>, <country>Pakistan</country></aff>
<aff id="aff3"><sup>3</sup><institution>School of Management Sciences, University Sains Malaysia</institution>, <addr-line>Penang</addr-line>, <country>Malaysia</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Government College University</institution>, <addr-line>Faisalabad</addr-line>, <country>Pakistan</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Health Science, Faculty of Public Governance and Business, Mykolas Romeris University</institution>, <addr-line>Vilnius</addr-line>, <country>Lithuania</country></aff>
<aff id="aff6"><sup>6</sup><institution>Faculty of Medicine, University of Oslo</institution>, <addr-line>Oslo</addr-line>, <country>Norway</country></aff>
<aff id="aff7"><sup>7</sup><institution>Infectious Diseases Department, Alnoor Specialist Hospital, Ministry of Health</institution>, <addr-line>Makkah</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff8"><sup>8</sup><institution>Pharmacy Department, Alnoor Specialist Hospital, Ministry of Health</institution>, <addr-line>Makkah</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff9"><sup>9</sup><institution>Department of Clinical Pharmacy, Faculty of Pharmacy, Al-Baha University</institution>, <addr-line>Al-Baha</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff10"><sup>10</sup><institution>Department of Pharmaceutical Practices, College of Pharmacy, Umm Al-Qura University</institution>, <addr-line>Makkah</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff11"><sup>11</sup><institution>OPD Pharmacy, Security Forces Hospital</institution>, <addr-line>Dammam</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff12"><sup>12</sup><institution>Department of Pharmacology and Toxicology, Faculty of Medicine in Al-Qunfudah, Umm Al-Qura University</institution>, <addr-line>Makkah</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff13"><sup>13</sup><institution>Pharmaceutical Care Department, Ministry of National-Guard Health Affairs</institution>, <addr-line>Jeddah</addr-line>, <country>Saudi Arabia</country></aff>
<aff id="aff14"><sup>14</sup><institution>Department of Clinical Pharmacy, College of Health Sciences and Nursing, Al-Rayan Colleges</institution>, <addr-line>Al-Madinah Al-Munawarah</addr-line>, <country>Saudi Arabia</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: Nyi Nyi Naing, Sultan Zainal Abidin University, Malaysia</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: Pragya Sharma, Maulana Azad medical College, India</p>
<p>Andrew Omame, Federal University of Technology Owerri, Nigeria</p>
<p>Rizaldy Taslim Pinzon, Duta Wacana Christian University, Indonesia</p>
<p>Dafeng Liu, Public Health and Clinical Center of Chengdu, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Anees ur Rehman, <email>aneesurrehman@bzu.edu.pk</email>; <email>aneesurrehmanr90@gmail.com</email></corresp>
<corresp id="c002">Zermina Tasleem, <email>zerminatasleem@bzu.edu.pk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1365744</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>01</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>07</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Rehman, Tasleem, Muhammad, Rasool, Shah, Jabeen, Arif, Omar Babkair, Kadumi, Alghamdi, Almarzoky Abuhussain, Khayyat, Alharthi, Hossain, Abbas, Elrggal and Haseeb.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Rehman, Tasleem, Muhammad, Rasool, Shah, Jabeen, Arif, Omar Babkair, Kadumi, Alghamdi, Almarzoky Abuhussain, Khayyat, Alharthi, Hossain, Abbas, Elrggal and Haseeb</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>The COVID-19 comorbid population is at higher risk of developing severe health issues like acute respiratory distress syndrome, coagulation syndrome, metabolic acidosis, and septic shock, potentially leading to patient death. Patients&#x2019; knowledge, attitudes, and practices (KAP) significantly influence their response to the pandemic and aid in enhancing health policy implementation.</p>
</sec>
<sec id="sec2">
<title>Objective</title>
<p>To identify and evaluate the pattern and associated factors to COVID-19 knowledge, attitude, and practice among individuals with comorbidities.</p>
</sec>
<sec id="sec3">
<title>Methodology</title>
<p>The systematic review followed the PRISMA guidelines. Relevant studies assessing the KAP of comorbid patients were retrieved by carefully searching the PubMed and Google Scholar databases. The appraisal tool for cross-sectional studies was used to determine the quality of the included studies and the risk of biases.</p>
</sec>
<sec id="sec4">
<title>Results</title>
<p>Eighteen studies met the inclusion criteria and were included in the review. The pooled sample size of the included studies was 9,104. Different comorbidities reported in the studies include hypertension, diabetes, psychological disorders, and cancer. Pooled analysis showed that 65% of patients showed good knowledge, 57% of patients showed a positive attitude and 51% of patients followed good practices to manage the COVID-19 in presence of their comorbid condition. Significant factors impacting knowledge, attitude and practice in COVID-19 comorbid patients were ethnicity OR 1.78 [95% CI 1.35&#x2013;2.32]; educational status 3.2 [2.79&#x2013;3.58]; urban residence 2.43 [1.65&#x2013;3.02]; employment Status 1.67[1.34&#x2013;2.12]; financial Status 4.02[3.66&#x2013;4.38]; occupation 3.65[3.31&#x2013;4.25]; information Source 2.64[2.19&#x2013;3.26]; comorbidity 3.28[2.78&#x2013;3.61]; and duration of chronic illness 1.59[1.31&#x2013;2.04].</p>
</sec>
<sec id="sec5">
<title>Conclusion</title>
<p>Comorbid COVID-19 patients showed good knowledge, positive attitude and good practice towards the management of the disease.</p>
</sec>
</abstract>
<kwd-group>
<kwd>knowledge</kwd>
<kwd>attitude</kwd>
<kwd>practice</kwd>
<kwd>KAP</kwd>
<kwd>hypertension</kwd>
<kwd>chronic illness</kwd>
<kwd>comorbidity</kwd>
<kwd>COVID-19</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="50"/>
<page-count count="12"/>
<word-count count="7083"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Public Health Education and Promotion</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec6">
<title>Introduction</title>
<p>The coronavirus disease is an extremely contagious and infectious pulmonary disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-COV2). The first outbreak was initiated in Wuhan, China, in December 2019, and soon it blew out throughout the globe due to a higher spread rate (<xref ref-type="bibr" rid="ref1">1</xref>). It infected a large population of the world in a short time interval. The emergence and widespread prevalence of coronavirus disease have resulted in severe consequences in different dimensions. According to the World Health Organization (WHO), COVID-19 has affected almost 470 million people throughout the globe, with a death rate of 3.4% (<xref ref-type="bibr" rid="ref2">2</xref>, <xref ref-type="bibr" rid="ref3">3</xref>). Due to the high infection rate and associated mortality, COVID-19 was declared as Public Health Emergency of International Concern by the WHO at the start of 2020 (<xref ref-type="bibr" rid="ref4">4</xref>).</p>
<p>The SARS-CoV-2-infected patients are mostly asymptomatic or generally experience mild symptoms that include fever, dry cough, sore throat, myalgia, fever, and fatigue. Comorbidities may cause different complications in patients suffering from COVID-19. In addition to the above-mentioned symptoms, the comorbid COVID-19 population is more vulnerable to developing acute respiratory distress syndrome, coagulation syndrome, metabolic acidosis, and septic shock, which may result in patient death (<xref ref-type="bibr" rid="ref5">5</xref>). Thus, COVID-19 patients with associated comorbid conditions, including hypertension, pregnancy, cardiovascular diseases, diabetes, renal disease, and respiratory diseases, are categorized as high-risk patients (<xref ref-type="bibr" rid="ref6">6</xref>). These high risk comorbid COVID-19 Patients experience a twofold increase in the necessity for mechanical ventilation, and a threefold elevation in the likelihood of developing severe disease or requiring admission to the intensive care unit (ICU) (<xref ref-type="bibr" rid="ref7">7</xref>, <xref ref-type="bibr" rid="ref8">8</xref>). Comorbid COVID-19 patients are at increased risk of mortality as compared to COVID-19 patients without comorbidity. Data collected from several global locations, encompassing both news outlets and scientific publications, has indicated that the overall case-fatality rate of COVID-19, standing at 3.4%, is more than three times greater (7.3%) in people with preexisting co-morbidities (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref9 ref10 ref11">9&#x2013;11</xref>).</p>
<p>Given the lack of a targeted therapeutic intervention for COVID-19, it is imperative that individuals with underlying health conditions adopt additional precautions and rigorously adhere to recommended practices of maintaining physical distance and practising proper hand hygiene. This approach is essential for facilitating the most effective management of their health. The acceptance of these preventive and therapeutic measures is contingent upon an individual&#x2019;s level of awareness and knowledge regarding the infection caused by COVID-19 (<xref ref-type="bibr" rid="ref12">12</xref>). KAP surveys are commonly employed in health behavior research to gather data on the knowledge, attitudes, and practices of individuals regarding a specific scientific topic. They exhibit characteristics that are representative of the specific demographic under study. The collected data serves as a means of assessing the state of community education (<xref ref-type="bibr" rid="ref13">13</xref>). The role of citizens&#x2019; knowledge, attitudes, and practices (KAP) has been widely acknowledged as crucial in effectively managing previous pandemics (<xref ref-type="bibr" rid="ref13">13</xref>). In the context of the 2009 Swine Flu pandemic, health officials were informed by KAP surveys and systematic evaluations about the necessary measures to implement to contain the transmission of emerging viruses and mitigate the impact of future pandemics (<xref ref-type="bibr" rid="ref14">14</xref>).</p>
<p>The comprehension of individuals&#x2019; attitudes helps predict and influence their behavior. Understanding disease states can contribute to improving patient well-being, mitigating disease advancement, and reducing the likelihood of hospitalization and mortality (<xref ref-type="bibr" rid="ref15">15</xref>, <xref ref-type="bibr" rid="ref16">16</xref>). Consequently, it is anticipated that the knowledge, attitudes, and practices (KAP) levels among individuals with comorbidities will serve as the determining factor in their battle against the COVID-19 pandemic and to effectively tailor educational interventions aimed at enhancing the application of health policies (<xref ref-type="bibr" rid="ref17">17</xref>). This approach is crucial in mitigating the transmission and proliferation of diseases (<xref ref-type="bibr" rid="ref12">12</xref>).</p>
<p>Given the nature of the COVID-19 pandemic, it is imperative to regularly update scientific literature to facilitate the production of empirical research on interventions and strategies that can enhance the efficacy of efforts aimed at mitigating the impact of the COVID-19 pandemic (<xref ref-type="bibr" rid="ref18">18</xref>). To achieve this objective, it is imperative to conduct a comprehensive and up-to-date systematic evaluation of the existing body of data. There are a limited number of systematic reviews and meta-analyses available that have examined the knowledge, attitudes, and practises (KAP) related to COVID-19. All the available systematic reviews on KAP of COVID-19 have their own limitations. Few reviews focused on KAP of general population (<xref ref-type="bibr" rid="ref19 ref20 ref21 ref22">19&#x2013;22</xref>), some are about KAP of healthcare professionals (<xref ref-type="bibr" rid="ref20">20</xref>), some are focused on the KAP of specific country (America and Ethiopia) (<xref ref-type="bibr" rid="ref23">23</xref>, <xref ref-type="bibr" rid="ref24">24</xref>). To the best of authors&#x2019; knowledge, there has been no comprehensive review conducted to assess the effects of KAP on patients with comorbidities. Taking into consideration the constraints outlined in the existing body of literature, the present systematic review and meta-analysis aimed to identify and evaluate the pattern and associated factors to COVID-19 knowledge, attitude, and practice among individuals with comorbidities. This study has the potential to inform the formulation of policies aimed at providing support to vulnerable groups, particularly individuals with comorbidities, to mitigate mortality rates, minimise the adverse effects on the healthcare system, and prevent economic downturn.</p>
</sec>
<sec sec-type="methods" id="sec7">
<title>Methodology</title>
<sec id="sec8">
<title>Search process</title>
<p>The systematic review followed the PRISMA guidelines (<xref ref-type="bibr" rid="ref25">25</xref>). Relevant studies assessing the KAP of comorbid patients were retrieved by carefully searching the PubMed and Google Scholar databases until September 15, 2023 (the date last searched). For PUBMED Search terms used were, &#x201C;COVID-19&#x201D; OR &#x201C;SARS-CoV-2&#x201D; OR &#x201C;2019 nCoV&#x201D; OR &#x201C;novel coronavirus&#x201D; OR &#x201C;new coronavirus&#x201D; OR &#x201C;severe acute respiratory syndrome coronavirus 2&#x201D; OR &#x201C;Wuhan and coronavirus&#x201D; OR &#x201C;pathogenesis&#x201D; OR &#x201C;infection&#x201D; OR &#x201C;transmission&#x201D; AND &#x201C;KAP&#x201D; OR &#x201C;knowledge&#x201D; OR &#x201C;attitude&#x201D; OR &#x201C;perception&#x201D; OR &#x201C;practice&#x201D; OR &#x201C;awareness&#x201D; OR &#x201C;action&#x201D; AND &#x201C;comorbidity&#x201D; OR &#x201C;diabetes&#x201D; OR &#x201C;hypertension&#x201D; OR &#x201C;pulmonary disorder&#x201D; OR &#x201C;renal failure&#x201D; OR &#x201C;cancer&#x201D; OR &#x201C;chronic disorder.&#x201D; Moreover, included reference lists were manually searched to address all the published evidence.</p>
</sec>
<sec id="sec9">
<title>Eligibility criteria</title>
<p>The systematic review included all the studies meeting the set inclusion criteria (1) cross-sectional studies, (2) well defined COVID-19 patients, (3) reporting at least one comorbid condition (diabetes, hypertension, pulmonary disorder, renal failure, and cancer), (4) investigating at least one or all components of KAP (knowledge, attitude and practice) model in COVID-19 patients, (5) published in peer reviewed journal. KAP studies in the general population, healthcare workers, systematic reviews, and any study published in a language other than English were excluded. The results measured in the included studies were knowledge, attitudes, and practices related to COVID-19 in comorbid patients.</p>
<p>The study selection approach employed the explicit method to prevent biases (<xref ref-type="bibr" rid="ref26">26</xref>, <xref ref-type="bibr" rid="ref27">27</xref>). Explicit method involves rigorously adhering to stated inclusion criteria during the search process. The objective is to offer more dependable conclusions. The papers that met the inclusion and exclusion criteria, as determined by the abstract and title, were carefully examined by three reviewers. Any disagreements between the reviewers were resolved through discussion until a consensus was achieved.</p>
</sec>
<sec id="sec10">
<title>Selection of studies and data extraction</title>
<p>Titles and abstracts were screened to assess articles for inclusion in the study. Two reviewers independently extracted data in a predesigned data extraction sheet in Excel software. Extracted information included author name, country, year, study period, study design, inclusion and exclusion criteria, method, target population, number and age of participants, study outcomes (knowledge, attitude, practice) and their associated factors. Any discrepancies between the two reviewers were resolved through discussion or by the involvement of the third reviewer (principal investigator) unless consensus was reached.</p>
</sec>
<sec id="sec11">
<title>Study outcomes</title>
<p>The primary outcomes of the meta-analysis focused on three key areas: knowledge (including understanding of symptoms, transmission methods, high risk populations, incubation and isolation periods, virus fatality rates, and prevention and treatment of COVID-19 infection), attitude (regarding the control and management of COVID-19), and practice (such as hand hygiene, social distancing, using face masks, avoiding crowded places, and adhering to isolation measures). The included studies collected responses using &#x201C;Yes/No/Do not know&#x201D; or &#x201C;Strongly agree/Agree/Neutral/Disagree/Strongly disagree&#x201D; items. The responses of &#x201C;Yes,&#x201D; &#x201C;True,&#x201D; or &#x201C;Strongly agree/Agree&#x201D; were considered positive responses for the analysis. The secondary outcomes encompassed the reported factors that affect the knowledge, attitude, and practice of comorbid COVID-19 patients towards the management of disease.</p>
</sec>
<sec id="sec12">
<title>Quality assessment and risk of biasness</title>
<p>The appraisal tool for cross-sectional studies (AXIS) was used to determine the quality of the included studies and the risk of biases (<xref ref-type="bibr" rid="ref28">28</xref>). The tool has 20 questions, and each question carries one score. Based on the quality assessment tool scores, the studies were categorized as follows: scores (&#x003E;15) were considered to have less biasness and good quality, (<xref ref-type="bibr" rid="ref10 ref11 ref12 ref13 ref14 ref15">10&#x2013;15</xref>) were considered to have moderate biasness and fair quality while (&#x003C;10) were considered to have higher biasness and poor quality.</p>
</sec>
<sec id="sec13">
<title>Statistical analysis</title>
<p>The retrieved studies provided quantitative data on the percentage of knowledge, attitudes, and practices (KAP) related to COVID-19 among patients with comorbidities. The pooled proportion of COVID-19 knowledge, attitudes, and practises (KAP) was computed and displayed using forest plots. The data on KAP-related factors was presented in the form of odds ratios (95% CI) for each component. The analysis was performed using a random effects model. The I<sup>2</sup> index was utilized to examine the heterogeneity of the study. Values of I<sup>2</sup> &#x2265;&#x2009;50% show higher heterogeneity. Sensitivity tests were conducted to assess the impact of the quality score categories of the included studies (results not shown). No missing data were reported in the study. A significance level of <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 was deemed as statistically significant. Statistical software package Stata V.16 (StataCorp, United States) was used for statistical analyses.</p>
</sec>
</sec>
<sec sec-type="results" id="sec14">
<title>Results</title>
<sec id="sec15">
<title>Search results</title>
<p>Originally, 468 articles were obtained after the initial search. After removing 23 duplicates, the remaining 445 articles were screened by title and abstract to retain 47 articles for full-text review. Eighteen studies met the inclusion criteria and were included in the review. The detailed inclusion and exclusion process is shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Systematic study selection process, in line with the PRISMA guidelines (<xref ref-type="bibr" rid="ref25">25</xref>).</p>
</caption>
<graphic xlink:href="fpubh-12-1365744-g001.tif"/>
</fig>
</sec>
<sec id="sec16">
<title>Characteristics of selected studies</title>
<p>Among the included studies, seven were performed in Ethiopia, two each in India, Pakistan, and Iran, and one each in Kuwait, Saudi Arabia, the US, Rwanda, and Romania. All the studies were cross-sectional. The pooled sample size of the included studies was 9,104, ranging from 64 to 1,585. The ages of the included patients range from 18 to 80&#x2009;years. Different comorbidities reported in the studies were hypertension, diabetes type 1 and 2, thyroid disorders, psychological disorders, depression, cancer, chronic pulmonary disease, heart disease, kidney disease, and HIV/AIDS. Eight studies show a low risk of bias, whereas 10 studies show a moderate risk of bias. The summaries of the included studies are demonstrated in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Summaries of the included studies.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Reference</th>
<th align="left" valign="top">Country</th>
<th align="center" valign="top">Year</th>
<th align="left" valign="top">Study design</th>
<th align="left" valign="top">Questionnaire</th>
<th align="center" valign="top">Participants</th>
<th align="center" valign="top">Age</th>
<th align="left" valign="top">Chronic Condition</th>
<th align="left" valign="top">Knowledge</th>
<th align="left" valign="top">Attitude</th>
<th align="left" valign="top">Practice</th>
<th align="left" valign="top">Factors Associated with KAP</th>
<th align="left" valign="top">Risk of Biasness</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Taye et al. (<xref ref-type="bibr" rid="ref29">29</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Self-developed</td>
<td align="center" valign="top">423</td>
<td align="center" valign="top">44.6</td>
<td align="left" valign="top">Hypertension, Diabetes</td>
<td align="left" valign="top">Good =37.59%</td>
<td align="left" valign="top">Positive =79.2%</td>
<td align="left" valign="top">Good =10.4%</td>
<td align="left" valign="top">Age, Occupation, ethnicity, source of information</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Addis SG et al. (<xref ref-type="bibr" rid="ref13">13</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">Pre-tested,</td>
<td align="center" valign="top">413</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Good =34.6%<break/>Moderate =35.1%<break/>Poor =25.7%</td>
<td align="left" valign="top">Positive =81.4%<break/>Moderate =12.1%<break/>Negative&#x2009;=&#x2009;6.5%</td>
<td align="left" valign="top">Good =40.7%<break/>Moderate =24.7%<break/>Poor&#x2009;=&#x2009;34.6%</td>
<td align="left" valign="top">age, urban residency, secondary education, comorbidity, gender</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Akalu et al. (<xref ref-type="bibr" rid="ref18">18</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">Pre-tested, structured</td>
<td align="center" valign="top">404</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">Hypertension, diabetes mellitus, heart disease, chronic lung disease</td>
<td align="left" valign="top">Poor =33.9%</td>
<td align="left" valign="top">Negative =41%</td>
<td align="left" valign="top">Poor =47.3%</td>
<td align="left" valign="top">Age, educational status, urban residence, financial status</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Iyasu et al. (<xref ref-type="bibr" rid="ref30">30</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Self-developed</td>
<td align="center" valign="top">422</td>
<td align="center" valign="top">NA</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Poor&#x2009;=&#x2009;35.1%.</td>
<td align="left" valign="top">Negative =40.5%</td>
<td align="left" valign="top">Poor =48.8%</td>
<td align="left" valign="top">Age, Education, Urban residency</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Geleta et al. (<xref ref-type="bibr" rid="ref31">31</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">structured questionnaire</td>
<td align="center" valign="top">360</td>
<td align="center" valign="top">NA</td>
<td align="left" valign="top">Hypertension</td>
<td align="left" valign="top">Good =58.3%</td>
<td align="left" valign="top">Positive =55.3%</td>
<td align="left" valign="top">Good =58.3%</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Legese et al.(<xref ref-type="bibr" rid="ref32">32</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2023</td>
<td align="left" valign="top">cross-sectional study</td>
<td align="left" valign="top">WHO guidelines</td>
<td align="center" valign="top">319</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">NA</td>
<td align="left" valign="top">Good =51.1%</td>
<td align="left" valign="top">Positive =59.9%</td>
<td align="left" valign="top">Good =49.2%</td>
<td align="left" valign="top">Age, gender, level of education, religion, marital status, occupation, urban residence</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Adella et al. (<xref ref-type="bibr" rid="ref33">33</xref>)</td>
<td align="left" valign="top">Ethiopia</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">structured, interviewer-administered</td>
<td align="center" valign="top">409</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">Hypertension, Diabetes mellitus</td>
<td align="left" valign="top">Good =79.2%</td>
<td align="left" valign="top">Positive =70.9%</td>
<td align="left" valign="top">Good =58.2%</td>
<td align="left" valign="top">Age, education level</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Saeed et al. (<xref ref-type="bibr" rid="ref12">12</xref>)</td>
<td align="left" valign="top">India</td>
<td align="center" valign="top">202`</td>
<td align="left" valign="top">cross-sectional online survey</td>
<td align="left" valign="top">Self-designed</td>
<td align="center" valign="top">260</td>
<td align="center" valign="top">&#x2265;30</td>
<td align="left" valign="top">Hypertension, Diabetes mellitus, Thyroid disorders</td>
<td align="left" valign="top">Good =82.7%</td>
<td align="left" valign="top">Positive =75.0%</td>
<td align="left" valign="top">Good =51.2%</td>
<td align="left" valign="top">Age&#x2009;&#x2265;&#x2009;50, Comorbidity, Education, occupation</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Pal et al. (<xref ref-type="bibr" rid="ref16">16</xref>)</td>
<td align="left" valign="top">India</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Self-developed</td>
<td align="center" valign="top">223</td>
<td align="center" valign="top">18&#x2013;30</td>
<td align="left" valign="top">Type 1 diabetes mellitus (T1DM)</td>
<td align="left" valign="top">Good =83%</td>
<td align="left" valign="top">Positive =98%</td>
<td align="left" valign="top">Good =64%</td>
<td align="left" valign="top">Age, financial status, duration of disease, education, urban residence</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Rajan et al. (<xref ref-type="bibr" rid="ref34">34</xref>)</td>
<td align="left" valign="top">Bangladesh &#x0026; Pakistan</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Self-developed,</td>
<td align="center" valign="top">845 &#x0026; 454</td>
<td align="center" valign="top">N</td>
<td align="left" valign="top">Schizophrenia, bipolar disorder, schizoaffective disorder, depression</td>
<td align="left" valign="top">Bng<break/>Good =74.61%<break/>Pak<break/>Good =60%</td>
<td align="left" valign="top">Bng<break/>Negative =29.94%<break/>Pak<break/>Negative =44.96</td>
<td align="left" valign="top">Bng<break/>Poor =26.5%<break/>Pak<break/>Poor =28.4%</td>
<td align="left" valign="top">Gender, information source</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Khatta et al. (<xref ref-type="bibr" rid="ref35">35</xref>)</td>
<td align="left" valign="top">Pakistan</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">structured questionnaire</td>
<td align="center" valign="top">208</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">breast cancer, skin cancer, lung cancer</td>
<td align="left" valign="top">Good =93%</td>
<td align="left" valign="top">Positive =94.2%</td>
<td align="left" valign="top">Good =90%</td>
<td align="left" valign="top">Gender, marital status, employment status,</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Alsaleh et al. (<xref ref-type="bibr" rid="ref36">36</xref>)</td>
<td align="left" valign="top">Kuwait</td>
<td align="center" valign="top">2023</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">self-administered</td>
<td align="center" valign="top">251</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">type 1 or type 2 diabetes</td>
<td align="left" valign="top">Moderate =71.1%</td>
<td align="left" valign="top">Positive =90.9%</td>
<td align="left" valign="top">Good =83.6%</td>
<td align="left" valign="top">Age, gender, marital status, financial status</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Subyani et al. (<xref ref-type="bibr" rid="ref37">37</xref>)</td>
<td align="left" valign="top">Saudia Arabia</td>
<td align="center" valign="top">2022</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">NA</td>
<td align="center" valign="top">64</td>
<td align="center" valign="top">18&#x2013;65</td>
<td align="left" valign="top">Type 1 Diabetes</td>
<td align="left" valign="top">Good&#x2009;=&#x2009;6.25%<break/>Moderate =43.75%<break/>Poor =11.50%</td>
<td align="left" valign="top">Positive =42.2%<break/>Negative =37.5</td>
<td align="left" valign="top">Good =64.1%<break/>Poor =48.8%</td>
<td/>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Wolf et al. (<xref ref-type="bibr" rid="ref8">8</xref>)</td>
<td align="left" valign="top">US</td>
<td align="center" valign="top">2020</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Interviews</td>
<td align="center" valign="top">630</td>
<td align="center" valign="top">23&#x2013;88</td>
<td align="left" valign="top">Heart disease, pulmonary disease, diabetes, hypertension, polypharmacy</td>
<td align="left" valign="top">Poor =28.3%</td>
<td align="left" valign="top">Negative =30.2%</td>
<td align="left" valign="top">Poor =21.9%</td>
<td align="left" valign="top">Ethnicity, Financial status, Education</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Mohamadian et al. (<xref ref-type="bibr" rid="ref38">38</xref>)</td>
<td align="left" valign="top">Iran</td>
<td align="center" valign="top">2023</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">Self-developed</td>
<td align="center" valign="top">368</td>
<td align="center" valign="top">&#x2265;18</td>
<td align="left" valign="top">Type2 Diabetes</td>
<td align="left" valign="top">Good =74.22%</td>
<td align="left" valign="top">Positive =72.88%</td>
<td align="left" valign="top">Good =70.51%</td>
<td/>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Jasim Alsadaji et al. (<xref ref-type="bibr" rid="ref39">39</xref>)</td>
<td align="left" valign="top">Iran &#x0026; Iraq</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">Self-developed</td>
<td align="center" valign="top">1,000</td>
<td align="center" valign="top">NA</td>
<td align="left" valign="top">Respiratory disease, heart disease, hypertension, Kidney disease, Diabetes</td>
<td align="left" valign="top">Good 49.33%</td>
<td align="left" valign="top">Positive =73.30</td>
<td align="left" valign="top">Good =74.62%</td>
<td align="left" valign="top">teaching hospitals</td>
<td align="left" valign="top">Moderate</td>
</tr>
<tr>
<td align="left" valign="top">Iradukunda et al. (<xref ref-type="bibr" rid="ref40">40</xref>)</td>
<td align="left" valign="top">Rwanda</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">cross-sectional</td>
<td align="left" valign="top">WHO recommendations</td>
<td align="center" valign="top">376</td>
<td align="center" valign="top">NA</td>
<td align="left" valign="top">HIV/AIDS</td>
<td align="left" valign="top">Good =97%</td>
<td align="left" valign="top">Positive =74%</td>
<td align="left" valign="top">Good =90%</td>
<td align="left" valign="top">Age, gender, urban residence, employment, duration of chronic illness</td>
<td align="left" valign="top">Low</td>
</tr>
<tr>
<td align="left" valign="top">Gheorghe et al. (<xref ref-type="bibr" rid="ref17">17</xref>)</td>
<td align="left" valign="top">Romania</td>
<td align="center" valign="top">2021</td>
<td align="left" valign="top">Cross-sectional</td>
<td align="left" valign="top">WHO recommendation</td>
<td align="center" valign="top">1,585</td>
<td align="center" valign="top">17&#x2013;87</td>
<td align="left" valign="top">Hypertension, Diabetes, Cardiac Diseases, Cancer</td>
<td align="left" valign="top">Good =10.8%<break/>Moderate =44.3%</td>
<td align="left" valign="top">Positive =32.6%</td>
<td align="left" valign="top">Good =55.5%</td>
<td/>
<td align="left" valign="top">Low</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p>KAP, Knowledge, attitude and practice; Bng: Bangladesh; Pak: Pakistan.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec17">
<title>The pattern of knowledge towards COVID-19</title>
<p><xref ref-type="fig" rid="fig2">Figure 2</xref> demonstrates the pooled proportion of the comorbid population with good knowledge about COVID-19 in the presence of their comorbid condition. Overall, 65% of the comorbid patients acquired good knowledge about COVID-19 and associated comorbidity (95% CI 43&#x2013;79%, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.001, I<sup>2</sup> =&#x2009;87%). Pooled analysis showed that in Ethiopia the comorbid population with knowledge was 49 to 84%. Country-wise, India 81% [95% CI 55&#x2013;89%], Bangladesh 71% [95% CI 42&#x2013;87%], Pakistan 83% [95% CI 49&#x2013;97%], Kuwait 65% [95% CI 37&#x2013;79%], Saudia Arabia 77% [95% CI 52&#x2013;82%], US 45% [95% CI 31&#x2013;58%], Iran 63% [95% CI 29&#x2013;77%], Iraq 58% [95% CI 36&#x2013;69%], Rwanda 51% [95% CI 31&#x2013;62%], Romania 52% [95% CI 33&#x2013;67%] population acquire good knowledge regarding management of COVID-19 along with comorbid condition. High Heterogenicity (I<sup>2</sup>&#x2009;=&#x2009;87%) was reported among studies.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Pooled proportion of Knowledge in Comorbid COVID-19 patients.</p>
</caption>
<graphic xlink:href="fpubh-12-1365744-g002.tif"/>
</fig>
</sec>
<sec id="sec18">
<title>The pattern of attitude towards COVID-19</title>
<p><xref ref-type="fig" rid="fig3">Figure 3</xref> demonstrates the pooled proportion of the comorbid population with a positive attitude toward COVID-19 in the presence of their comorbid condition. Overall, 57% of the comorbid patients showed a positive attitude to managing COVID-19 and associated comorbidity (95% CI 49&#x2013;69%, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001, I<sup>2</sup> =&#x2009;83%). Pooled analysis showed that in Ethiopia the comorbid population with a positive attitude to manage COVID-19 and associated comorbidity were 37 to 72%. Country-wise, India 91% [95% CI 75&#x2013;97%], Bangladesh 41% [95% CI 34&#x2013;49%], Pakistan 82% [95% CI 71&#x2013;98%], Kuwait 81% [95% CI 69&#x2013;88%], Saudia Arabia 42% [95% CI 35&#x2013;49%], US 48% [95% CI 38&#x2013;66%], Iran 72% [95% CI 64&#x2013;82%], Iraq 41% [95% CI 32&#x2013;63%], Rwanda 39% [95% CI 32&#x2013;57%] and Romania 43% [95% CI 33&#x2013;49%] population showed positive attitude to manage COVID-19 along with comorbid condition. High Heterogenicity (I<sup>2</sup>&#x2009;=&#x2009;83%) was reported among studies.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Pooled proportion of positive attitude in Comorbid COVID-19 patients.</p>
</caption>
<graphic xlink:href="fpubh-12-1365744-g003.tif"/>
</fig>
</sec>
<sec id="sec19">
<title>The pattern of practice towards COVID-19</title>
<p><xref ref-type="fig" rid="fig4">Figure 4</xref> demonstrates the pooled proportion of the comorbid COVID-19 population following good preventive practices to manage the COVID-19 in presence of their comorbid condition. Overall, 51% of the comorbid COVID-19 patients adopted good preventive practices to manage the COVID-19 in presence of their comorbid condition (95% CI 40&#x2013;63%, <italic>p</italic>&#x2009;&#x003C;&#x2009;0.0001, I<sup>2</sup> =&#x2009;91%). Pooled analysis showed that in Ethiopia 31 to 56% of patients adopted good preventive practices. Country-wise, India 51% [95% CI 45&#x2013;67%], Bangladesh 42% [95% CI 33&#x2013;55%], Pakistan 61% [95% CI 52&#x2013;75%], Kuwait 61% [95% CI 49&#x2013;67%], Saudia Arabia 53% [95% CI 45&#x2013;62%], US 34% [95% CI 27&#x2013;42%], Iran 77% [95% CI 63&#x2013;91%], Iraq 55% [95% CI 48&#x2013;66%], Rwanda 43% [95% CI 34&#x2013;55%] and Romania 68% [95% CI 56&#x2013;85%] population were following good preventive practices to manage the COVID-19 in presence of their comorbid condition. Higher heterogenicity (I<sup>2</sup>&#x2009;=&#x2009;91%) was reported among studies.</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>Pooled proportion of good preventive practices in Comorbid COVID-19 patients.</p>
</caption>
<graphic xlink:href="fpubh-12-1365744-g004.tif"/>
</fig>
</sec>
<sec id="sec20">
<title>Factors related to COVID-19 knowledge attitude and practice</title>
<p>Different factors affecting the knowledge, attitude, and preventive practices to manage the COVID-19 in presence of comorbidity are shown in <xref ref-type="fig" rid="fig5">Figure 5</xref> with odd ratios, 95% CI, <italic>p</italic> values, I<sup>2</sup> statistics and forest plot. Significant factors (OR [95% CI]) impacting knowledge, attitude and practice in COVID-19 comorbid patients were ethnicity 1.78 [1.35&#x2013;2.32]; educational status 3.2 [2.79&#x2013;3.58]; urban residence 2.43 [1.65&#x2013;3.02]; employment Status 1.67[1.34&#x2013;2.12]; financial Status 4.02[3.66&#x2013;4.38]; occupation 3.65[3.31&#x2013;4.25]; information Source 2.64[2.19&#x2013;3.26]; comorbidity 3.28[2.78&#x2013;3.61]; and duration of chronic illness 1.59[1.31&#x2013;2.04].</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Factors affecting the knowledge, attitude, and preventive practices to manage the COVID-19 in presence of comorbidity.</p>
</caption>
<graphic xlink:href="fpubh-12-1365744-g005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec21">
<title>Discussion</title>
<p>We recognized a limited body of evidence determining the pattern and associated factors of COVID-19 knowledge, attitude, and practice among comorbid COVID-19 patients. Our results showed good knowledge, a positive attitude and good practice to manage COVID-19 in the presence of comorbidity. In addition, good knowledge, positive attitude and good practice were related to age, ethnicity, educational status, urban residence, employment status, financial status, occupation, information Source, comorbidity and duration of chronic illness. Age was reported as an important factor in 11 studies, educational status in eight studies, urban residence and gender in six studies, financial status in four studies, employment status, marital status and occupation in three studies and ethnicity, religion, information source, comorbidity and duration of chronic illness in two studies each.</p>
<p>Adequate knowledge and awareness of preventive strategies are important to manage COVID-19 in comorbid patients (<xref ref-type="bibr" rid="ref41">41</xref>). Our results showed good knowledge about COVID-19 in 65% of the COVID-19 comorbid patients. Most of the patients were aware of the symptoms of COVID-19 including dyspnea, sore throat, fever, chills, and associated risks due to the comorbid conditions. Cancer patients and diabetes patients&#x2019; cardiovascular patients were able to distinguish the COVID-19 symptoms and their respective disease symptoms. Our results are in line with the previous research that shows higher knowledge about COVID-19 management in comorbid patients (<xref ref-type="bibr" rid="ref35">35</xref>, <xref ref-type="bibr" rid="ref36">36</xref>). This may be due to the fact chronic disease patients are in regular contact with healthcare professionals due to their disease condition. Frequent contact with healthcare providers and discussions may improve their knowledge of the pandemic COVID-19.</p>
<p>In our results, 57% of the comorbid patients showed a positive attitude to managing COVID-19 and associated comorbidity. Most of the patients knew COVID-19 may cause more harmful effects in the presence of their disease. Cancer patients believe that COVID-19 increases the risk of mortality so they must adopt extra preventive measures to avoid COVID-19 exposure. Diabetic patients think that they need to manage their diet and physical activity to improve immunity against COVID-19. Our results are in line with the previous literature which shows a positive attitude of 58 and 47% of hypertension and diabetic patients, respectively, toward COVID-19 management (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>). Usually, chronic disease patients have better disease management knowledge as compared to healthy people (<xref ref-type="bibr" rid="ref42 ref43 ref44">42&#x2013;44</xref>). So, most of them believe that government policies and restrictions to prevent COVID-19 are for the benefit of the people and can control the pandemic.</p>
<p>Overall, published articles showed the constructive attitude of the participants about COVID-19, which is consistent with the findings of the study conducted in Indonesia (96%) (<xref ref-type="bibr" rid="ref45">45</xref>). It could be due to better health policies and knowledge about the disease. However, the study done in Northern Ethiopia revealed that 40.5% of the included participants showed a negative attitude towards the prevention of COVID-19 (<xref ref-type="bibr" rid="ref30">30</xref>). The possible reason for negative attitudes can be poor knowledge about the disease and the unfamiliar nature of COVID-19. Our finding demonstrated that a substantial part of the comorbid patients were concerned about the probability of COVID-19 infection and mortality due to infection. These findings were consistent with those in the Philippines and the United States (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref46">46</xref>).</p>
<p>Regarding practice, in most studies, participants adopted regular measures to prevent COVID-19 disease. In pooled analysis, 57% of comorbid patients adopted preventive measures to avoid COVID-19. Diabetic patients believe regular physical activity is necessary for them to manage diabetes but they must avoid parks and crowded places to avoid COVID-19 exposure. Comorbid patients need to visit the pharmacy regularly to refill prescriptions or take insulin. Most of the comorbid patients left their houses to visit pharmacies. Policies to provide insulin and other medicines at doorsteps can reduce pharmacy visits and further improve preventive practices in comorbid patients.</p>
<p>This systematic review revealed several factors associated with KAP towards COVID-19 among participants including age, ethnicity, educational status, urban residence, employment status, financial status, occupation, information Source, comorbidity and duration of chronic illness. Younger age was associated with better KAP toward COVID-19 than older age. Different studies reported that people younger than 40 years had better knowledge and positive attitudes toward the management of their disease (<xref ref-type="bibr" rid="ref16">16</xref>). This may be because young people are more frequent users of social media and adopt change easily. Social media is a key source of information these days. So, this may be the reason for better COVID-19-related KAP in young people. Occupation, financial status and education were also reported as significant factors to impact KAP in comorbid COVID-19 patients in previous research. Studies conducted in Ethiopia, India and Egypt reported occupation, financial status and education as contributing factors to the impact of KAP in comorbid COVID-19 patients (<xref ref-type="bibr" rid="ref12">12</xref>, <xref ref-type="bibr" rid="ref30">30</xref>, <xref ref-type="bibr" rid="ref47">47</xref>). Comorbidity and duration of chronic illness were also associated with better KAP in comorbid COVID-19 patients. With an increase in the duration of disease self-management practice and knowledge improve. Research shows that compliance increases with the duration of chronic disease. Thus, with the increased duration of the disease, people may become more conscious of the management of a disease.</p>
<p>Higher heterogeneity was reported among COVID-19 KAP studies. The higher heterogeneity may be due to due to variations in illness manifestation, characteristics of the population being studied, and the methodologies employed in the research (<xref ref-type="bibr" rid="ref48">48</xref>, <xref ref-type="bibr" rid="ref49">49</xref>). The diverse demographics of these research participants, regional variations in healthcare systems, environmental variables, population genetics demographic factors, comorbidities, and the varying severity of COVID-19 lead to heterogeneity. Diagnostic and testing methods are also a factor in the diversity. Heterogeneity can also be caused by variations in study design and methodologies (<xref ref-type="bibr" rid="ref26">26</xref>, <xref ref-type="bibr" rid="ref27">27</xref>). The quality of data and the outcomes obtained differ depending on the type of study conducted, such as observational studies, randomised controlled trials, retrospective studies, or prospective studies. The variety of findings is influenced by the variations in data collection procedures, duration of follow-up, and outcome measures. Study outcomes are also influenced by epidemiological factors such as pandemic waves and new variants that have varying levels of transmissibility and pathogenicity (<xref ref-type="bibr" rid="ref22">22</xref>, <xref ref-type="bibr" rid="ref38">38</xref>, <xref ref-type="bibr" rid="ref42">42</xref>).</p>
<p>Notwithstanding its robustness, this study has few limitations. Most of the research conducted took place during the epidemic and primarily consisted of online or telephonic questionnaires. Consequently, individuals lacking access to these amenities may have been deprived of participation. The presence of diverse methods resulted in increased heterogeneity in the studies. Furthermore, the exclusion of grey literature, which was not included in this study due to the availability of sufficient peer-reviewed data, may potentially lead to the omission of certain information. Despite a few limitations, this study has several strengths. The study identified a significant portion of the accessible data and yielded valuable insights into the Knowledge, Attitudes, and Practices (KAP) regarding COVID-19 among individuals with comorbidities. To the best of the author&#x2019;s knowledge, this study was the first systematic review and meta-analysis to evaluate knowledge attitudes and practices towards COVID-19 and its associated factors in comorbid patients. The anticipated outcomes of the study are expected to bring attention to areas of research that have not been well addressed. This information will be valuable for health professionals in making informed decisions and for developing policies and programs that are specifically targeted at addressing these gaps. The findings have the potential to enhance our understanding of the impact of the pandemic on individuals with chronic diseases, in terms of their knowledge, attitudes, and practices (KAP). Consequently, this could potentially contribute to the enhancement of patient safety and the provision of high-quality care, while also mitigating the transmission of COVID-19 among individuals at a heightened risk.</p>
<p>The COVID-19 pandemic has highlighted the importance of prioritizing vulnerable populations, particularly those with chronic conditions. Millions have died due to inadequate preparedness and responses. In addition to the implementation of efficacious solutions for the prevention and treatment of disease, a positive attitude and practice of the population to adopt preventive measures is also important. Our research shows that by giving priority to vulnerable groups, such as individuals with other chronic illnesses, it is possible to implement focused interventions, enhance access to crucial healthcare services, and implement public health policies (<xref ref-type="bibr" rid="ref50">50</xref>). Implementation of effective strategies to improve knowledge, including information sources, targeted information, and enhanced telecommunication contact with healthcare providers can improve the attitude of comorbid patients toward the pandemic control. Moreover, media partnerships, digital educational materials, online medicine refills, extended medical supply distribution, hotlines, health protocols, and home visits can be effective in protecting individuals and maintaining care.</p>
</sec>
<sec sec-type="data-availability" id="sec22">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="author-contributions" id="sec23">
<title>Author contributions</title>
<p>AR: Conceptualization, Formal analysis, Supervision, Writing &#x2013; original draft. ZT: Supervision, Writing &#x2013; review &#x0026; editing. SM: Software, Writing &#x2013; review &#x0026; editing. MFR: Writing &#x2013; review &#x0026; editing. SS: Writing &#x2013; review &#x0026; editing. GJ: Formal analysis, Writing &#x2013; review &#x0026; editing. SA: Formal analysis, Writing &#x2013; review &#x0026; editing. LO: Writing &#x2013; review &#x0026; editing. YK: Writing &#x2013; review &#x0026; editing. SaA: Writing &#x2013; review &#x0026; editing. SSA: Writing &#x2013; review &#x0026; editing. SK: Writing &#x2013; review &#x0026; editing. RA: Writing &#x2013; review &#x0026; editing. MH: Writing &#x2013; review &#x0026; editing. AA: Writing &#x2013; review &#x0026; editing. ME: Writing &#x2013; review &#x0026; editing, Resources. AH: Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec24">
<title>Funding</title>
<p>The author(s) declare no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>The authors are very grateful to the teaching faculty of the Department of Pharmacy Practice, Bahauddin Zakariya University Multan, who gave their valuable feedback on the systematic review and to the library staff for searching and requesting the full-text articles from the authors.</p>
</ack>
<sec sec-type="COI-statement" id="sec25">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="sec26">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>F</given-names></name> <name><surname>Zhao</surname> <given-names>S</given-names></name> <name><surname>Yu</surname> <given-names>B</given-names></name> <name><surname>Chen</surname> <given-names>YM</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Song</surname> <given-names>ZG</given-names></name> <etal/></person-group>. <article-title>A new coronavirus associated with human respiratory disease in China</article-title>. <source>Nature</source>. (<year>2020</year>) <volume>579</volume>:<fpage>265</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id>, PMID: <pub-id pub-id-type="pmid">32015508</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="other"><person-group person-group-type="author"><collab id="coll1">World Health Organization</collab></person-group> The true death toll of COVID-19: Estimating global excess mortality. (<year>2022</year>) Available at: <ext-link xlink:href="https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality" ext-link-type="uri">https://www.who.int/data/stories/the-true-death-toll-of-covid-19-estimating-global-excess-mortality</ext-link></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="book"><person-group person-group-type="author"><collab id="coll2">World Health Organization</collab></person-group>. <source>World Health Organization coronavirus disease (COVID-19) dashboard</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name> (<year>2020</year>).</citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>D</given-names></name> <name><surname>Tou</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Chen</surname> <given-names>Q</given-names></name> <name><surname>Wang</surname> <given-names>W</given-names></name> <name><surname>Huang</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Prevention and control strategies for emergency, limited-term, and elective operations in pediatric surgery during the epidemic period of COVID-19. World</article-title>. <source>J Pediatr Surg</source>. (<year>2020</year>) <volume>3</volume>:<fpage>122</fpage>. doi: <pub-id pub-id-type="doi">10.1136/wjps-2020-000122</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ejaz</surname> <given-names>H</given-names></name> <name><surname>Alsrhani</surname> <given-names>A</given-names></name> <name><surname>Zafar</surname> <given-names>A</given-names></name> <name><surname>Javed</surname> <given-names>H</given-names></name> <name><surname>Junaid</surname> <given-names>K</given-names></name> <name><surname>Abdalla</surname> <given-names>AE</given-names></name> <etal/></person-group>. <article-title>COVID-19 and comorbidities: deleterious impact on infected patients</article-title>. <source>J Infect Public Health</source>. (<year>2020</year>) <volume>13</volume>:<fpage>1833</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jiph.2020.07.014</pub-id>, PMID: <pub-id pub-id-type="pmid">32788073</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barone</surname> <given-names>MTU</given-names></name> <name><surname>Ngongo</surname> <given-names>B</given-names></name> <name><surname>Harnik</surname> <given-names>SB</given-names></name> <name><surname>de Oliveira</surname> <given-names>LX</given-names></name> <name><surname>V&#x00E9;gh</surname> <given-names>D</given-names></name> <name><surname>de Luca</surname> <given-names>PV</given-names></name> <etal/></person-group>. <article-title>COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis</article-title>. <source>Diabetes Res Clin Pract</source>. (<year>2021</year>) <volume>171</volume>:<fpage>108587</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.diabres.2020.108587</pub-id>, PMID: <pub-id pub-id-type="pmid">33307134</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oraibi</surname> <given-names>O</given-names></name> <name><surname>Alamer</surname> <given-names>A</given-names></name> <name><surname>Zogel</surname> <given-names>B</given-names></name> <name><surname>Hakami</surname> <given-names>F</given-names></name> <name><surname>Hakami</surname> <given-names>K</given-names></name> <name><surname>Gadi</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Impact of COVID-19 on patients with diabetes standard of Care in the Jazan Region, Saudi Arabia</article-title>. <source>Mater Sociomed</source>. (<year>2022</year>) <volume>34</volume>:<fpage>272</fpage>&#x2013;<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.5455/msm.2022.34.272-277</pub-id>, PMID: <pub-id pub-id-type="pmid">36936887</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname> <given-names>MS</given-names></name> <name><surname>Serper</surname> <given-names>M</given-names></name> <name><surname>Opsasnick</surname> <given-names>L</given-names></name> <name><surname>O'Conor</surname> <given-names>RM</given-names></name> <name><surname>Curtis</surname> <given-names>L</given-names></name> <name><surname>Benavente</surname> <given-names>JY</given-names></name> <etal/></person-group>. <article-title>Awareness, attitudes, and actions related to COVID-19 among adults with chronic conditions at the onset of the U.S. outbreak</article-title>. <source>Ann Intern Med</source>. (<year>2020</year>) <volume>173</volume>:<fpage>100</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.7326/M20-1239</pub-id>, PMID: <pub-id pub-id-type="pmid">32271861</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname> <given-names>WJ</given-names></name> <name><surname>Ni</surname> <given-names>ZY</given-names></name> <name><surname>Hu</surname> <given-names>Y</given-names></name> <name><surname>Liang</surname> <given-names>WH</given-names></name> <name><surname>Ou</surname> <given-names>CQ</given-names></name> <name><surname>He</surname> <given-names>JX</given-names></name> <etal/></person-group>. <article-title>Clinical characteristics of coronavirus disease 2019 in China</article-title>. <source>N Engl J Med</source>. (<year>2020</year>) <volume>382</volume>:<fpage>1708</fpage>&#x2013;<lpage>20</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id>, PMID: <pub-id pub-id-type="pmid">32109013</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>S</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Liu</surname> <given-names>F</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <name><surname>Cao</surname> <given-names>G</given-names></name> <name><surname>Yang</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study</article-title>. <source>Hypertens Res</source>. (<year>2020</year>) <volume>43</volume>:<fpage>824</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41440-020-0485-2</pub-id>, PMID: <pub-id pub-id-type="pmid">32483311</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>D</given-names></name> <name><surname>Hu</surname> <given-names>B</given-names></name> <name><surname>Hu</surname> <given-names>C</given-names></name> <name><surname>Zhu</surname> <given-names>F</given-names></name> <name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</article-title>. <source>JAMA</source>. (<year>2020</year>) <volume>323</volume>:<fpage>1061</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id>, PMID: <pub-id pub-id-type="pmid">32031570</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saeed</surname> <given-names>S</given-names></name> <name><surname>Awasthi</surname> <given-names>AA</given-names></name> <name><surname>Nandi</surname> <given-names>D</given-names></name> <name><surname>Kaur</surname> <given-names>K</given-names></name> <name><surname>Hasan</surname> <given-names>S</given-names></name> <name><surname>Janardhanan</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitude and practice towards COVID-19 among individuals with associated comorbidities</article-title>. <source>J Med Life</source>. (<year>2021</year>) <volume>14</volume>:<fpage>225</fpage>&#x2013;<lpage>37</lpage>. doi: <pub-id pub-id-type="doi">10.25122/jml-2020-0184</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Addis</surname> <given-names>SG</given-names></name> <name><surname>Nega</surname> <given-names>AD</given-names></name> <name><surname>Miretu</surname> <given-names>DG</given-names></name></person-group>. <article-title>Knowledge, attitude and practice of patients with chronic diseases towards COVID-19 pandemic in Dessie town hospitals, Northeast Ethiopia</article-title>. <source>Diabetes Metab Syndr Clin Res Rev</source>. (<year>2021</year>) <volume>15</volume>:<fpage>847</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.dsx.2021.03.033</pub-id>, PMID: <pub-id pub-id-type="pmid">33873054</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>L</given-names></name> <name><surname>Savoia</surname> <given-names>E</given-names></name> <name><surname>Agboola</surname> <given-names>F</given-names></name> <name><surname>Viswanath</surname> <given-names>K</given-names></name></person-group>. <article-title>What have we learned about communication inequalities during the H1N1 pandemic: a systematic review of the literature</article-title>. <source>J BMC public health</source>. (<year>2014</year>) <volume>14</volume>:<fpage>1</fpage>&#x2013;<lpage>13</lpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2458-14-484</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Magnani</surname> <given-names>JW</given-names></name> <name><surname>Mujahid</surname> <given-names>MS</given-names></name> <name><surname>Aronow</surname> <given-names>HD</given-names></name> <name><surname>Cen&#x00E9;</surname> <given-names>CW</given-names></name> <name><surname>Dickson</surname> <given-names>VV</given-names></name> <name><surname>Havranek</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association</article-title>. <source>Circulation</source>. (<year>2018</year>) <volume>138</volume>:<fpage>e48</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000000579</pub-id>, PMID: <pub-id pub-id-type="pmid">29866648</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname> <given-names>R</given-names></name> <name><surname>Yadav</surname> <given-names>U</given-names></name> <name><surname>Grover</surname> <given-names>S</given-names></name> <name><surname>Saboo</surname> <given-names>B</given-names></name> <name><surname>Verma</surname> <given-names>A</given-names></name> <name><surname>Bhadada</surname> <given-names>SK</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitudes and practices towards COVID-19 among young adults with type 1 diabetes mellitus amid the nationwide lockdown in India: a cross-sectional survey</article-title>. <source>Diabetes Res Clin Pract</source>. (<year>2020</year>) <volume>166</volume>:<fpage>108344</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.diabres.2020.108344</pub-id>, PMID: <pub-id pub-id-type="pmid">32710997</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gheorghe</surname> <given-names>A</given-names></name> <name><surname>Negru</surname> <given-names>&#x015E;</given-names></name> <name><surname>Ni&#x021B;ipir</surname> <given-names>C</given-names></name> <name><surname>Mazilu</surname> <given-names>L</given-names></name> <name><surname>Marinca</surname> <given-names>M</given-names></name> <name><surname>Gafton</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey</article-title>. <source>Ann Oncol</source>. (<year>2021</year>) <volume>6</volume>:<fpage>100027</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.esmoop.2020.100027</pub-id>, PMID: <pub-id pub-id-type="pmid">33399089</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akalu</surname> <given-names>Y</given-names></name> <name><surname>Ayelign</surname> <given-names>B</given-names></name> <name><surname>Molla</surname> <given-names>MD</given-names></name></person-group>. <article-title>Knowledge, attitude and practice towards COVID-19 among chronic disease patients at Addis Zemen hospital Northwest Ethiopia</article-title>. <source>Infect Drug Resist</source>. (<year>2020</year>) <volume>13</volume>:<fpage>1949</fpage>&#x2013;<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S258736</pub-id>, PMID: <pub-id pub-id-type="pmid">32612371</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raquib</surname> <given-names>A</given-names></name> <name><surname>Raquib</surname> <given-names>R</given-names></name> <name><surname>Jamil</surname> <given-names>S</given-names></name> <name><surname>Hossain</surname> <given-names>A</given-names></name> <name><surname>al-Mamun</surname> <given-names>F</given-names></name> <name><surname>Mamun</surname> <given-names>MA</given-names></name></person-group>. <article-title>Knowledge, attitudes, and practices toward the prevention of COVID-19 in Bangladesh: a systematic review and Meta-analysis</article-title>. <source>Front Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>856156</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2022.856156</pub-id>, PMID: <pub-id pub-id-type="pmid">35733876</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bekele</surname> <given-names>F</given-names></name> <name><surname>Sheleme</surname> <given-names>T</given-names></name> <name><surname>Fekadu</surname> <given-names>G</given-names></name> <name><surname>Bekele</surname> <given-names>K</given-names></name></person-group>. <article-title>Patterns and associated factors of COVID-19 knowledge, attitude, and practice among general population and health care workers: a systematic review</article-title>. <source>SAGE Open Med</source>. (<year>2020</year>) <volume>8</volume>:<fpage>205031212097072</fpage>. doi: <pub-id pub-id-type="doi">10.1177/2050312120970721</pub-id>, PMID: <pub-id pub-id-type="pmid">33240497</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saadatjoo</surname> <given-names>S</given-names></name> <name><surname>Miri</surname> <given-names>M</given-names></name> <name><surname>Hassanipour</surname> <given-names>S</given-names></name> <name><surname>Ameri</surname> <given-names>H</given-names></name> <name><surname>Arab-Zozani</surname> <given-names>MJPH</given-names></name></person-group>. <article-title>Knowledge, attitudes, and practices of the general population about coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis with policy recommendations</article-title>. <source>Public Health</source>. (<year>2021</year>) <volume>194</volume>:<fpage>185</fpage>&#x2013;<lpage>95</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.puhe.2021.03.005</pub-id>, PMID: <pub-id pub-id-type="pmid">33962095</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname> <given-names>MM</given-names></name> <name><surname>Marzo</surname> <given-names>RR</given-names></name> <name><surname>Chowdhury</surname> <given-names>S</given-names></name> <name><surname>Qalati</surname> <given-names>SA</given-names></name> <name><surname>Hasan</surname> <given-names>MN</given-names></name> <name><surname>Paul</surname> <given-names>GK</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitude and practices toward coronavirus disease (COVID-19) in southeast and South Asia: a mixed study design approach</article-title>. <source>J Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>875727</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.875727</pub-id>, PMID: <pub-id pub-id-type="pmid">35801233</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarria-Guzm&#x00E1;n</surname> <given-names>Y</given-names></name> <name><surname>Fusaro</surname> <given-names>C</given-names></name> <name><surname>Bernal</surname> <given-names>JE</given-names></name> <name><surname>Mosso-Gonz&#x00E1;lez</surname> <given-names>C</given-names></name> <name><surname>Gonz&#x00E1;lez-Jim&#x00E9;nez</surname> <given-names>FE</given-names></name> <name><surname>Serrano-Silva</surname> <given-names>N</given-names></name></person-group>. <article-title>Knowledge, attitude and practices (KAP) towards COVID-19 pandemic in America: a preliminary systematic review</article-title>. <source>JIDC</source>. (<year>2021</year>) <volume>15</volume>:<fpage>9</fpage>&#x2013;<lpage>21</lpage>. doi: <pub-id pub-id-type="doi">10.3855/jidc.14388</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Azene</surname> <given-names>AG</given-names></name> <name><surname>Workie</surname> <given-names>MS</given-names></name> <name><surname>Aragaw</surname> <given-names>AMJCTR</given-names></name></person-group>. <article-title>Knowledge, attitude, and prevention practices toward coronavirus disease 2019 in Ethiopia: a systematic review and Meta-analysis</article-title>. <source>Curr Ther Res Clin Exp</source>. (<year>2021</year>) <volume>94</volume>:<fpage>100633</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.curtheres.2021.100633</pub-id>, PMID: <pub-id pub-id-type="pmid">33972804</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname> <given-names>A</given-names></name> <name><surname>Altman</surname> <given-names>DG</given-names></name> <name><surname>Tetzlaff</surname> <given-names>J</given-names></name> <name><surname>Mulrow</surname> <given-names>C</given-names></name> <name><surname>G&#x00F8;tzsche</surname> <given-names>PC</given-names></name> <name><surname>Ioannidis</surname> <given-names>JP</given-names></name> <etal/></person-group>. <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</article-title>. <source>PLoS Med</source>. (<year>2009</year>) <volume>6</volume>:<fpage>e1000100</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pmed.1000100</pub-id>, PMID: <pub-id pub-id-type="pmid">19621070</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anees Ur</surname> <given-names>R</given-names></name> <name><surname>Ahmad Hassali</surname> <given-names>MA</given-names></name> <name><surname>Muhammad</surname> <given-names>SA</given-names></name> <name><surname>Shah</surname> <given-names>S</given-names></name> <name><surname>Abbas</surname> <given-names>S</given-names></name> <name><surname>Hyder Ali</surname> <given-names>IAB</given-names></name> <etal/></person-group>. <article-title>The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature</article-title>. <source>Expert Rev Pharmacoecon Outcomes Res</source>. (<year>2020</year>) <volume>20</volume>:<fpage>661</fpage>&#x2013;<lpage>72</lpage>. doi: <pub-id pub-id-type="doi">10.1080/14737167.2020.1678385</pub-id>, PMID: <pub-id pub-id-type="pmid">31596632</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>A</given-names></name> <name><surname>Hassali</surname> <given-names>MAA</given-names></name> <name><surname>Muhammad</surname> <given-names>SA</given-names></name> <name><surname>Harun</surname> <given-names>SN</given-names></name> <name><surname>Shah</surname> <given-names>S</given-names></name> <name><surname>Abbas</surname> <given-names>S</given-names></name></person-group>. <article-title>The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature</article-title>. <source>Eur J Health Econ</source>. (<year>2020</year>) <volume>21</volume>:<fpage>181</fpage>&#x2013;<lpage>94</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10198-019-01119-1</pub-id>, PMID: <pub-id pub-id-type="pmid">31564007</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Downes</surname> <given-names>MJ</given-names></name> <name><surname>Brennan</surname> <given-names>ML</given-names></name> <name><surname>Williams</surname> <given-names>HC</given-names></name> <name><surname>Dean</surname> <given-names>RS</given-names></name></person-group>. <article-title>Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)</article-title>. <source>BMJ Open</source>. (<year>2016</year>) <volume>6</volume>:<fpage>e011458</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2016-011458</pub-id>, PMID: <pub-id pub-id-type="pmid">27932337</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taye</surname> <given-names>GM</given-names></name> <name><surname>Bose</surname> <given-names>L</given-names></name> <name><surname>Beressa</surname> <given-names>TB</given-names></name> <name><surname>Tefera</surname> <given-names>GM</given-names></name> <name><surname>Mosisa</surname> <given-names>B</given-names></name> <name><surname>Dinsa</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>COVID-19 knowledge, attitudes, and prevention practices among people with hypertension and diabetes mellitus attending public health facilities in ambo Ethiopia</article-title>. <source>Infect Drug Resist</source>. (<year>2020</year>) <volume>13</volume>:<fpage>4203</fpage>&#x2013;<lpage>14</lpage>. doi: <pub-id pub-id-type="doi">10.2147/IDR.S283999</pub-id>, PMID: <pub-id pub-id-type="pmid">33262615</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iyasu</surname> <given-names>A</given-names></name> <name><surname>Kidanu</surname> <given-names>BH</given-names></name> <name><surname>Zereabruk</surname> <given-names>K</given-names></name></person-group>. <article-title>Knowledge, attitude, and practice towards COVID-19 among chronic disease patients at Aksum hospital, northern Ethiopia, 2020: a cross-sectional study</article-title>. <source>Asthma Res Pract</source>. (<year>2021</year>) <volume>7</volume>:<fpage>1</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s40733-021-00074-0</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geleta</surname> <given-names>TA</given-names></name> <name><surname>Deriba</surname> <given-names>BS</given-names></name> <name><surname>Jemal</surname> <given-names>KJ</given-names></name></person-group>. <article-title>Evaluation of the knowledge, attitude, and practice of COVID-19 prevention methods among hypertensive patients in North Shoa, Ethiopia</article-title>. <source>Risk Manag Healthc Policy</source>. (<year>2022</year>) <volume>15</volume>:<fpage>457</fpage>&#x2013;<lpage>71</lpage>. doi: <pub-id pub-id-type="doi">10.2147/RMHP.S347105</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Legese</surname> <given-names>YM</given-names></name> <name><surname>Gebru</surname> <given-names>SB</given-names></name> <name><surname>Gebremariam</surname> <given-names>AG</given-names></name> <name><surname>Tesfay</surname> <given-names>ZAJH</given-names></name></person-group>. <article-title>Knowledge, attitude, and practice towards COVID-19 among chronic disease patients visiting public hospitals</article-title>. <source>Heliyon</source>. (<year>2023</year>) <volume>9</volume>:<fpage>e17734</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e17734</pub-id>, PMID: <pub-id pub-id-type="pmid">37441094</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adella</surname> <given-names>GA</given-names></name> <name><surname>Abebe</surname> <given-names>K</given-names></name> <name><surname>Atnafu</surname> <given-names>N</given-names></name> <name><surname>Azeze</surname> <given-names>GA</given-names></name> <name><surname>Alene</surname> <given-names>T</given-names></name> <name><surname>Molla</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitude, and intention to accept COVID-19 vaccine among patients with chronic diseases in southern Ethiopia: multi-center study</article-title>. <source>Front Public Health</source>. (<year>2022</year>) <volume>10</volume>:<fpage>917925</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2022.917925</pub-id>, PMID: <pub-id pub-id-type="pmid">36249216</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname> <given-names>S</given-names></name> <name><surname>Paton</surname> <given-names>LW</given-names></name> <name><surname>Chowdhury</surname> <given-names>AH</given-names></name> <name><surname>Zavala</surname> <given-names>GA</given-names></name> <name><surname>Aslam</surname> <given-names>F</given-names></name> <name><surname>Huque</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Knowledge and response to the COVID-19 pandemic in people with severe mental illness in Bangladesh and Pakistan: a cross-sectional survey</article-title>. <source>Front Psych</source>. (<year>2022</year>) <volume>13</volume>:<fpage>785059</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpsyt.2022.785059</pub-id>, PMID: <pub-id pub-id-type="pmid">35237185</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khattak</surname> <given-names>S</given-names></name> <name><surname>Faheem</surname> <given-names>M</given-names></name> <name><surname>Nawaz</surname> <given-names>B</given-names></name> <name><surname>Khan</surname> <given-names>M</given-names></name> <name><surname>Khan</surname> <given-names>NH</given-names></name> <name><surname>Ullah</surname> <given-names>N</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitude, and perception of Cancer patients towards COVID-19 in Pakistan: a cross-sectional study</article-title>. <source>IJERPH</source>. (<year>2022</year>) <volume>19</volume>:<fpage>7926</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph19137926</pub-id>, PMID: <pub-id pub-id-type="pmid">35805584</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alsaleh</surname> <given-names>FM</given-names></name> <name><surname>Elzain</surname> <given-names>M</given-names></name> <name><surname>Alsairafi</surname> <given-names>ZK</given-names></name> <name><surname>Naser</surname> <given-names>AY</given-names></name></person-group>. <article-title>Perceived knowledge, attitude, and practices (KAP) and fear toward COVID-19 among patients with diabetes attending primary healthcare centers in Kuwait</article-title>. <source>IJERPH</source>. (<year>2023</year>) <volume>20</volume>:<fpage>369</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph20032369</pub-id>, PMID: <pub-id pub-id-type="pmid">36767736</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Subyani</surname> <given-names>AA</given-names></name> <name><surname>Fadel</surname> <given-names>HA</given-names></name> <name><surname>Bokhary</surname> <given-names>A</given-names></name> <name><surname>Ghunaim</surname> <given-names>AM</given-names></name> <name><surname>Alharbi</surname> <given-names>HH</given-names></name> <name><surname>Alghamdi</surname> <given-names>KA</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitudes, and practices of COVID-19 safety measures among type 1 diabetes mellitus patients at king Abdulaziz university hospital: a cross-sectional study</article-title>. <source>Cureus</source>. (<year>2022</year>) <volume>14</volume>:<fpage>e27713</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.27713</pub-id>, PMID: <pub-id pub-id-type="pmid">36081971</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohamadian</surname> <given-names>H</given-names></name> <name><surname>faraji</surname> <given-names>A</given-names></name> <name><surname>Ghorrabi</surname> <given-names>AT</given-names></name> <name><surname>Ghobadi-Dashdebi</surname> <given-names>K</given-names></name> <name><surname>Salahshouri</surname> <given-names>A</given-names></name></person-group>. <article-title>The COVID-19 pandemic: knowledge, attitudes and practices of coronavirus (COVID-19) among patients with type 2 diabetes</article-title>. <source>J Diarrhoeal Dis Res</source>. (<year>2023</year>) <volume>42</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s41043-023-00349-7</pub-id>, PMID: <pub-id pub-id-type="pmid">36805712</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jasim Alsadaji</surname> <given-names>A</given-names></name> <name><surname>Zendeh Talab</surname> <given-names>HR</given-names></name> <name><surname>Jasim Mohammed</surname> <given-names>Z</given-names></name> <name><surname>HJMEB</surname> <given-names>BV</given-names></name></person-group>. <article-title>Comparison of knowledge, attitude, and practice of patients with chronic diseases referred to clinics affiliated with Iranian and Iraqi teaching hospitals regarding COVID-19</article-title>. <source>Med Edu Bull</source>. (<year>2021</year>) <volume>2</volume>:<fpage>263</fpage>&#x2013;<lpage>74</lpage>. doi: <pub-id pub-id-type="doi">10.22034/MEB.2021.312860.1035</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iradukunda</surname> <given-names>PG</given-names></name> <name><surname>Pierre</surname> <given-names>G</given-names></name> <name><surname>Muhozi</surname> <given-names>V</given-names></name> <name><surname>Denhere</surname> <given-names>K</given-names></name> <name><surname>Dzinamarira</surname> <given-names>T</given-names></name></person-group>. <article-title>Knowledge, attitude, and practice towards COVID-19 among people living with HIV/AIDS in Kigali, Rwanda</article-title>. <source>J Community Health</source>. (<year>2021</year>) <volume>46</volume>:<fpage>245</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10900-020-00938-1</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Erfani</surname> <given-names>A</given-names></name> <name><surname>Shahriarirad</surname> <given-names>R</given-names></name> <name><surname>Ranjbar</surname> <given-names>K</given-names></name> <name><surname>Mirahmadizadeh</surname> <given-names>A</given-names></name> <name><surname>Moghadami</surname> <given-names>M</given-names></name></person-group>. <article-title>Knowledge, attitude and practice toward the novel coronavirus (COVID-19) outbreak: a population-based survey in Iran</article-title>. <source>Bull World Health Organ</source>. (<year>2020</year>) <volume>30</volume>:<fpage>2471</fpage>.</citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>A</given-names></name> <name><surname>Shah</surname> <given-names>S</given-names></name> <name><surname>Abbas</surname> <given-names>G</given-names></name> <name><surname>Harun</surname> <given-names>SN</given-names></name> <name><surname>Shakeel</surname> <given-names>S</given-names></name> <name><surname>Hussain</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Assessment of risk factors responsible for rapid deterioration of lung function over a period of one year in patients with chronic obstructive pulmonary disease</article-title>. <source>Sci Rep</source>. (<year>2021</year>) <volume>11</volume>:<fpage>92968</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-92968-5</pub-id></citation></ref>
<ref id="ref43"><label>43.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname> <given-names>MF</given-names></name> <name><surname>Rehman</surname> <given-names>AU</given-names></name> <name><surname>Imran</surname> <given-names>I</given-names></name> <name><surname>Abbas</surname> <given-names>S</given-names></name> <name><surname>Shah</surname> <given-names>S</given-names></name> <name><surname>Abbas</surname> <given-names>G</given-names></name> <etal/></person-group>. <article-title>Risk factors associated with medication errors among patients suffering from chronic disorders</article-title>. <source>Front Public Health</source>. (<year>2020</year>) <volume>8</volume>:<fpage>531038</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2020.531038</pub-id>, PMID: <pub-id pub-id-type="pmid">33330300</pub-id></citation></ref>
<ref id="ref44"><label>44.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasool</surname> <given-names>MF</given-names></name> <name><surname>Rehman</surname> <given-names>A</given-names></name> <name><surname>Khan</surname> <given-names>I</given-names></name> <name><surname>Latif</surname> <given-names>M</given-names></name> <name><surname>Ahmad</surname> <given-names>I</given-names></name> <name><surname>Shakeel</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>Assessment of risk factors associated with potential drug-drug interactions among patients suffering from chronic disorders</article-title>. <source>PLoS One</source>. (<year>2023</year>) <volume>18</volume>:<fpage>e0276277</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0276277</pub-id>, PMID: <pub-id pub-id-type="pmid">36693042</pub-id></citation></ref>
<ref id="ref45"><label>45.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sari</surname> <given-names>DK</given-names></name> <name><surname>Amelia</surname> <given-names>R</given-names></name> <name><surname>Dharmajaya</surname> <given-names>R</given-names></name> <name><surname>Sari</surname> <given-names>LM</given-names></name> <name><surname>Fitri</surname> <given-names>NK</given-names></name></person-group>. <article-title>Positive correlation between general public knowledge and attitudes regarding COVID-19 outbreak 1 month after first cases reported in Indonesia</article-title>. <source>J Community Health</source>. (<year>2021</year>) <volume>46</volume>:<fpage>182</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10900-020-00866-0</pub-id>, PMID: <pub-id pub-id-type="pmid">32583360</pub-id></citation></ref>
<ref id="ref46"><label>46.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname> <given-names>LL</given-names></name> <name><surname>Hung</surname> <given-names>N</given-names></name> <name><surname>Go</surname> <given-names>DJ</given-names></name> <name><surname>Ferma</surname> <given-names>J</given-names></name> <name><surname>Choi</surname> <given-names>M</given-names></name> <name><surname>Dodd</surname> <given-names>W</given-names></name> <etal/></person-group>. <article-title>Knowledge, attitudes and practices of COVID-19 among income-poor households in the Philippines: a cross-sectional study</article-title>. <source>J Glob Health</source>. (<year>2020</year>) <volume>10</volume>:<fpage>1007</fpage>. doi: <pub-id pub-id-type="doi">10.7189/jogh.10.011007</pub-id>, PMID: <pub-id pub-id-type="pmid">32566169</pub-id></citation></ref>
<ref id="ref47"><label>47.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kebede</surname> <given-names>Y</given-names></name> <name><surname>Yitayih</surname> <given-names>Y</given-names></name> <name><surname>Birhanu</surname> <given-names>Z</given-names></name> <name><surname>Mekonen</surname> <given-names>S</given-names></name> <name><surname>Ambelu</surname> <given-names>A</given-names></name></person-group>. <article-title>Knowledge, perceptions and preventive practices towards COVID-19 early in the outbreak among Jimma university medical center visitors, Southwest Ethiopia</article-title>. <source>PLoS One</source>. (<year>2020</year>) <volume>15</volume>:<fpage>e0233744</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0233744</pub-id>, PMID: <pub-id pub-id-type="pmid">32437432</pub-id></citation></ref>
<ref id="ref48"><label>48.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khattak</surname> <given-names>M</given-names></name> <name><surname>Rehman</surname> <given-names>A</given-names></name> <name><surname>Muqaddas</surname> <given-names>T</given-names></name> <name><surname>Hussain</surname> <given-names>R</given-names></name> <name><surname>Rasool</surname> <given-names>MF</given-names></name> <name><surname>Saleem</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis</article-title>. <source>J Ann Med</source>. (<year>2024</year>) <volume>56</volume>:<fpage>683</fpage>. doi: <pub-id pub-id-type="doi">10.1080/07853890.2024.2313683</pub-id></citation></ref>
<ref id="ref49"><label>49.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>A</given-names></name> <name><surname>Khattak</surname> <given-names>M</given-names></name> <name><surname>Mushtaq</surname> <given-names>U</given-names></name> <name><surname>Latif</surname> <given-names>M</given-names></name> <name><surname>Ahmad</surname> <given-names>I</given-names></name> <name><surname>Rasool</surname> <given-names>MF</given-names></name> <etal/></person-group>. <article-title>The impact of diabetes mellitus on the emergence of multi-drug resistant tuberculosis and treatment failure in TB-diabetes comorbid patients: a systematic review and meta-analysis</article-title>. <source>J Front Public Health</source>. (<year>2023</year>) <volume>11</volume>:<fpage>1244450</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fpubh.2023.1244450</pub-id></citation></ref>
<ref id="ref50"><label>50.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname> <given-names>R</given-names></name> <name><surname>Hassali</surname> <given-names>MA</given-names></name> <name><surname>Ur Rehman</surname> <given-names>A</given-names></name> <name><surname>Muneswarao</surname> <given-names>J</given-names></name> <name><surname>Hashmi</surname> <given-names>F</given-names></name></person-group>. <article-title>Physicians&#x2019; understanding and practices of Pharmacovigilance: qualitative experience from A lower middle-income country</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2020</year>) <volume>17</volume>:<fpage>2209</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijerph17072209</pub-id></citation></ref>
</ref-list>
</back>
</article>